A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial.

  • Sohn, Joohyuk; 
  • Kim, Gun Min; 
  • Jung, Kyung Hae; 
  • Jeung, Hei-Cheul; 
  • Lee, Jieun; 
  • ... Park, Kyong Hwa; 
  • 외 14명
Citations

WEB OF SCIENCE

7

키워드

261-566-3248-2667; 261-566-3248-2733; 261-492-3532-2370-7650-5110; 283-217-2472; 261-3278; 261-566-3248-2667; 261-492-5651-2790; 261-492-3532-2370-7650-2700; 281-318-9490; 6; 6; 6; 5; 5; 3; 3; 3; 2; 295; 295; 1579; 65; 228; 8; 3; 2; 1; 1
제목
A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial.
저자
Sohn, Joohyuk; Kim, Gun Min; Jung, Kyung Hae; Jeung, Hei-Cheul; Lee, Jieun; Lee, Keun Seok; Im, Seock-Ah; Kang, Seok Yun; Kim, Se Hyun; Kim, Han Jo; Park, Kyong Hwa; Chae, Yee Soo; Koh, Su-Jin; Cho, Eun Kyung; Park, Keon Uk; Lee, Sung Sook; Kim, Ji-Yeon; Choi, In Sil; Baek, Sun Kyung; Moon, Yong Wha
DOI
10.1200/JCO.2024.42.17_suppl.LBA502
발행일
2024-06-10
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
권
42
호
17_SUPPL
페이지
LBA502 ~ LBA502